We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$27.8B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+31.84%
1 Year Est. Return
+46.46%
3 Year Est. Return
+129.16%
5 Year Est. Return
+174.16%
10 Year Est. Return
+698%
AUM
$27.8B
AUM Growth
+$4.02B
(+17%)
Cap. Flow
-$324M
Cap. Flow
% of AUM
-1.17%
Top 10 Holdings %
Top 10 Hldgs %
27.66%
Holding
1,111
New
158
Increased
319
Reduced
438
Closed
177
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$325M |
| 2 |
CrowdStrike
CRWD
|
+$225M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$186M |
| 4 |
SNDK
Sandisk
SNDK
|
+$155M |
| 5 |
Sysco
SYY
|
+$147M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$418M |
| 2 |
ServiceNow
NOW
|
+$262M |
| 3 |
Apple
AAPL
|
+$260M |
| 4 |
Masco
MAS
|
+$163M |
| 5 |
Roku
ROKU
|
+$139M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.14% |
| 2 | Financials | 13.01% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Industrials | 11.2% |
| 5 | Healthcare | 10.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Atea Pharmaceuticals
AVIR
$468M
| – | – |
-43,104
| Closed | -$232K |
|
952
Mission Produce
AVO
$1.12B
| – | – |
-107,282
| Closed | -$1.48M |
|
953
AvePoint
AVPT
$2.84B
| – | – |
-186,445
| Closed | -$1.77M |
|
954
Avnet
AVT
$7.56B
| – | – |
-3,546
| Closed | -$219K |
|
955
AXT Inc
AXTI
$4.04B
| – | – |
-13,438
| Closed | -$766K |
|
956
Acuity Brands
AYI
$10B
| – | – |
-66,251
| Closed | -$18.6M |
|
957
Ball Corp
BALL
$16.6B
| – | – |
-64,083
| Closed | -$3.79M |
|
|
BAND
958
Bandwidth Inc
BAND
$1.41B
| – | – |
-180,619
| Closed | -$3.22M |
|
959
Brunswick
BC
$4.82B
| – | – |
-30,483
| Closed | -$2.22M |
|
960
BioCryst Pharmaceuticals
BCRX
$2.55B
| – | – |
-1,004,373
| Closed | -$9.56M |
|
961
Benchmark Electronics
BHE
$2.61B
| – | – |
-24,072
| Closed | -$1.35M |
|
962
Biohaven
BHVN
$2.37B
| – | – |
-30,080
| Closed | -$254K |
|
|
BLD
963
DELISTED
TopBuild
BLD
| – | – |
-653
| Closed | -$229K |
|
964
Backblaze
BLZE
$833M
| – | – |
-174,576
| Closed | -$602K |
|
965
Biomea Fusion
BMEA
$147M
| – | – |
-310,514
| Closed | -$475K |
|
966
Broadridge
BR
$19.7B
| – | – |
-3,246
| Closed | -$527K |
|
967
Babcock & Wilcox
BW
$1.06B
| – | – |
-13,639
| Closed | -$200K |
|
|
CCRN
968
DELISTED
Cross Country Healthcare
CCRN
| – | – |
-617,010
| Closed | -$5.8M |
|
969
Cardlytics
CDLX
$21.3M
| – | – |
-5,310
| Closed | -$55.8K |
|
970
Cigna
CI
$74.7B
| – | – |
-49,979
| Closed | -$13.3M |
|
971
Columbus McKinnon
CMCO
$544M
| – | – |
-68,710
| Closed | -$998K |
|
972
CME Group
CME
$101B
| – | – |
-35,414
| Closed | -$10.5M |
|
973
Compass Therapeutics
CMPX
$429M
| – | – |
-30,655
| Closed | -$162K |
|
974
CenterPoint Energy
CNP
$26.1B
| – | – |
-455,872
| Closed | -$19.7M |
|
975
CRA International
CRAI
$1.07B
| – | – |
-8,184
| Closed | -$1.32M |
|
Similar funds
UIM
SSA
CAM
CM
Jacobs Levy Equity Management's Q2 2026 Portfolio in Review
As of Q2 2026, Jacobs Levy Equity Management held 1,111 positions worth $27.8B, up 17% from $23.8B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jacobs Levy Equity Management's Q2 2026 filing shows 158 new, 319 increased, 438 reduced and 177 closed positions. Its largest new stake was Sysco: 1,938,184 shares worth $162M. The largest sale was Qualcomm, an estimated $418M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2026 buy was Sysco: 1,938,184 shares worth $162M.
- Jacobs Levy Equity Management added most to KLA in Q2 2026, an estimated $325M increase.
- Jacobs Levy Equity Management's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $418M.
- Jacobs Levy Equity Management fully exited Roku in Q2 2026, selling an estimated $139M.
- Jacobs Levy Equity Management's ten largest holdings make up 28% of its $27.8B portfolio in Q2 2026.
- Jacobs Levy Equity Management opened 158 new positions and closed 177 in Q2 2026.
- Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $27.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.